key: cord-1010216-a9j3x0ii authors: Charlesworth, M.; Grossman, R. title: Pre‐operative SARS‐CoV‐2 testing, isolation, vaccination and remote prehabilitation – the road to ‘COVID‐19 secure’ elective surgery date: 2021-09-19 journal: Anaesthesia DOI: 10.1111/anae.15590 sha: 7b2b7e1b52473e7c8c870eef0a95e661a1ef93c6 doc_id: 1010216 cord_uid: a9j3x0ii nan more in those isolating ≥8 days, which is still shorter than recommendations in England for certain patient groups. The question is, can these new data be used to update guidelines and improve clinical practice? First, we must look to the methods used and then dive back into our recent prepandemic history when concepts such as prehabilitation and enhanced recovery dominated the peri-operative landscape and promised much for the future. This was a planned sub-study of a previously reported prospective cohort study [2] . The COVIDSurg and GlobalSurg collaboratives must again be congratulated on building the infrastructure required not only to execute the project and collect focused data on so many patients, but on setting out to provide rapid answers to important unknowns during a pandemic. They have provided the strongest data to date addressing the effect of isolation on postoperative pulmonary complications, and collaboration on this scale provides a blueprint for the future of peri-operative research. But there are limitations. In an ideal world, one would randomly allocate patients to isolation or control before surgery for a defined period and with strict adherence, or even enrol every elective surgical patient in the UK into an adaptive platform trial [5] . Neither of these options have been explored and this new contribution represents the best available evidence. Isolation before surgery was introduced without an evidence base and there has been almost no research on its risks and benefits. Only 26,948 (27.9%) patients isolated, which is surprisingly low. There are various associations reported and those who isolated were not simply older, higher risk patients undergoing more major procedures with general anaesthesia. This explains why the effect described is reliant upon correction for various measured confounders, with the uncorrected postoperative pulmonary complication rate similar in both groups. Some variables, such as the period of isolation and age, have been converted from continuous to ordinal data, which has well-described disadvantages [8] . It is difficult to see any benefits of pre-operative isolation from this analysis, both for patients and hospitals and even in areas of high SARS-CoV-2 community prevalence or when testing and COVID-19free surgical pathways are in use. An alternative explanation is that the study was not designed to detect these benefits, as it is not possible to determine, for example, how many cases of nosocomial transmission were prevented. Patient optimisation before surgery aims to get patients into the best possible position before surgery in order to at once improve patient outcomes, public health and increase the efficiency of healthcare [9] . Now, the gap between what we know about prehabilitation and enhanced recovery and how we implement their principles has never been wider, with COVID-19 having completely disordered progress towards streamlined re-engineered prehabilitation pathways [10] . There are three factors lending support to isolation alone being far from the main culprit in a new age of 'reverse prehabilitation'. First, many might be unpersuaded that an independent association between a short period of isolation and the incidence of postoperative pulmonary complications is biologically plausible [11] . Second, those who isolated may have also shielded before isolation. Little is known yet about the sequelae of shielding and its effect on intra-and postoperative complications, but an association here is perhaps more plausible. Third, optimising comorbidities requires access to relevant clinics, yet many of these services have been pressured during the pandemic due to staff shortages. Those who isolated may have also had less access to these services. They might have also isolated if it was easier for them to do so, and those less likely to be going outside might be frailer and at higher risk for postoperative pulmonary complications. Therefore, the effect seen here might not be explained by the relatively short period of isolation before surgery, with subtle unmeasured confounders almost certainly at play. What does seem reasonable is the need now to think about how to implement prehabilitation into COVID-19 surgical pathways. Bringing all pre-operative patients to hospital in person to optimise their physical and mental condition before surgery is no longer feasible. Any strategy to mitigate the risk of COVID-19-associated complications must be patient and organisation specific. The new evidence provided here generates an interesting hypothesis yet does not allow complete relaxation of all isolation practices for all patients. At best, it asks questions of the need to isolate patients for the full 14 days as compared with 3 days, especially in combination with preoperative SARS-CoV-2 testing and vaccination [12, 13] . This will provide flexibility as we strive to clear the backlog of operations that have been cancelled due to the pandemic [14, 15] . For patients who isolate, there must be renewed focus on home prehabilitation. Three days isolation following a SARS-CoV-2 polymerase chain reaction swab test for all patients seems a pragmatic place to start, but organisations may struggle to balance the harms of isolation against the need for precaution. They will want to ensure absolutely everything possible is done, and patients will continue to take on some of that burden in exchange for surgery. Requests for long periods of isolation to prevent nosocomial transmission will become more problematic when there is a signal that it causes harm for no benefit. Enforcing and adherence to isolation is also increasingly impractical. Moreover, nosocomial transmission is a hospital-related problem, and organisations must think about other areas where gains can be made, such as: mandating the use of airborne precautions for those caring for COVID-19 patients on wards; rethinking practices around 'aerosol-generating procedures' in patients who do not have COVID-19 [16] ; and ensuring adequate ventilation in all indoor spaces. Offering elective surgery to a patient who has refused a vaccine, where it is free and available, will continue to present a moral dilemma for many. So too now is working out where to draw the line between benefit and harm for pre-operative isolation. Reaffirming health and safety precautionary principles for COVID-19 in the UK Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study Nosocomial SARS-CoV-2 transmission in postoperative infection and mortality: analysis of 14 798 procedures Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study Adaptive platform trials: definition, design, conduct and reporting considerations Definitions of anaesthetic technique and the implications for clinical research A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications The cost of dichotomising continuous variables Patient optimisation before surgery: a clear and present challenge in peri-operative care Perioperative care pathways: re-engineering care to achieve the 'triple aim Negative outcomes in critical care trials: applying the wrong statistics -or asking the wrong questions? SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans The impact of COVID-19 on anaesthesia and critical care services in the UK: a serial service evaluation A quantitative evaluation of aerosol generation during supraglottic airway insertion and removal MC is an Editor of Anaesthesia. No other competing interests declared.